Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection. 1982

G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg

HBsAg was determined quantitatively by radioimmunoassay and by Laurell electrophoresis in sera of 90 patients with acute hepatitis B, 57 patients with chronic hepatitis B, and 154 HBsAg positive blood donors. Of 55 patients with clearance of HBsAg from the circulation within six months, 54 (98%) showed an at least 50% reduction in concentration within 16 days. All 55 patients had such a decrease within 20 days. No such decrease was found in seven patients with acute hepatitis B who became HBsAg carriers. Therefore, quantitative HBsAg concentration in paired sera seems to be a reliable and early prognostic marker in acute hepatitis B. In patients with clearance of HBsAg most of the antigen is already present in the circulation at hospitalization and is eliminated with a mean half-life of 8.8 days. Patients with chronic hepatitis exhibit on average nearly the same HBsAg concentration (about 40,000 ng/ml) as patients with acute hepatitis B at hospitalization (about 39,000 ng/ml) and HBsAg positive blood donors on average a lower HBsAg concentration (about 8,000 ng/ml).

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
June 2023, Cureus,
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
September 1984, The Journal of infection,
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
October 1987, Gastroenterology,
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
June 2014, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi,
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
August 2011, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
May 1985, Archives of pathology & laboratory medicine,
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
February 2016, Medicine,
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
December 2017, Immune network,
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
November 2016, Hepatology (Baltimore, Md.),
G G Frösner, and H Schomerus, and K H Wiedmann, and R Zachoval, and B Bayerl, and U Bäcker, and G A Gathof, and U Sugg
November 1975, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!